Suchergebnisse - "Carlo-Stella, Carmelo"

PubPharm (8)

1

A phase Ib, open-label, dose-escalation trial of the anti-CD37 monoclonal antibody, BI 836826, in combination with gemcitabine and oxaliplatin in patients with relapsed/refractory diffuse large B-cell lymphoma

enthalten in: Investigational new drugs | 2021

von Balzarotti, M. | Magagnoli, M. | Canales, M. | +8

2

A phase Ib, open-label, dose-escalation trial of the anti-CD37 monoclonal antibody, BI 836826, in combination with gemcitabine and oxaliplatin in patients with relapsed/refractory diffuse large B-cell lymphoma

enthalten in: Investigational new drugs | 2021

von Balzarotti, M. | Magagnoli, M. | Canales, M. | +8

3

A phase Ib, open-label, dose-escalation trial of the anti-CD37 monoclonal antibody, BI 836826, in combination with gemcitabine and oxaliplatin in patients with relapsed/refractory diffuse large B-cell lymphoma

enthalten in: Investigational new drugs | 2021

von Balzarotti, M. | Magagnoli, M. | Canales, M. | +8

4

A phase Ib, open-label, dose-escalation trial of the anti-CD37 monoclonal antibody, BI 836826, in combination with gemcitabine and oxaliplatin in patients with relapsed/refractory diffuse large B-cell lymphoma

enthalten in: Investigational new drugs | 2021

von Balzarotti, M. | Magagnoli, M. | Canales, M. | +8

5

Novel second mitochondria-derived activator of caspases (Smac) mimetic compounds sensitize human leukemic cell lines to conventional chemotherapeutic drug-induced and death receptor-mediated apoptosis

enthalten in: Investigational new drugs | 2011

von Servida, F. | Lecis, D. | Scavullo, C. | +8

6

Novel second mitochondria-derived activator of caspases (Smac) mimetic compounds sensitize human leukemic cell lines to conventional chemotherapeutic drug-induced and death receptor-mediated apoptosis

enthalten in: Investigational new drugs | 2010

von Servida, F. | Lecis, D. | Scavullo, C. | +8

7

Novel second mitochondria-derived activator of caspases (Smac) mimetic compounds sensitize human leukemic cell lines to conventional chemotherapeutic drug-induced and death receptor-mediated apoptosis

enthalten in: Investigational new drugs | 2010

von Servida, F. | Lecis, D. | Scavullo, C. | +8

8

Novel second mitochondria-derived activator of caspases (Smac) mimetic compounds sensitize human leukemic cell lines to conventional chemotherapeutic drug-induced and death receptor-mediated apoptosis

enthalten in: Investigational new drugs | 2010

von Servida, F. | Lecis, D. | Scavullo, C. | +8

1
[1]